Group recommends targeting CER for priority populations
This article was originally published in The Tan Sheet
Executive Summary
Federal agencies should target comparative effectiveness research funds for studies involving racial and ethnic minorities, children, women, the elderly and people with multiple chronic conditions, the Brookings Institution's Engelberg Center for Health Care Reform says. The center's draft report recommends government organizations that support CER "allocate research funds to meritorious investigator-initiated proposals that are responsive to priority populations, and create targeted funding opportunities to fill gaps." The health care reform Congress enacted in March requires CER and gives oversight to a federal institute operating in a public/private partnership mode (1"The Tan Sheet" April 19, 2010). The draft notes research does not focus enough on conditions that affect priority populations, and priority populations typically are not recruited for trials. Another problem is the clinical trials infrastructure is not set up to allow for more participation from members of priority groups
You may also be interested in...
Comparative Effectiveness Could Take A Close Look At CAM - Sebelius
Comparative effectiveness research required under health care reform likely will be used to carefully test the value of complementary and alternative medicines rather than simply hold up those products as less-expensive alternatives to pharmaceuticals
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.